Spinal cord schistosomiasis: a prospective study of 63 cases emphasizing clinical and therapeutic aspects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000980:Antiplatyhelmintic Agents / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D017116:Low Back Pain / Q000453:epidemiology / Q000209:etiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000503:physiopathology; D009422:Nervous System Diseases / Q000209:etiology / Q000503:physiopathology; D009460:Neurologic Examination; D020818:Neuroschistosomiasis / Q000175:diagnosis / Q000469:parasitology / Q000628:therapy*; D010146:Pain / Q000209:etiology; D010147:Pain Measurement; D018579:Patient Selection; D011223:Praziquantel / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D011843:Radiculopathy / Q000469:parasitology / Q000503:physiopathology; D012026:Reflex, Stretch / Q000502:physiology; D013116:Spinal Cord / Q000469:parasitology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000980:Antiplatyhelmintic Agents; D007074:Immunoglobulin G; D011223:Praziquantel; D011241:Prednisone; D008775:Methylprednisolone